3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Polycystic Ovary Syndrome
17
Colorectal Neoplasms
7
Lung Neoplasms
4
Ovarian Neoplasms
3
Infertility
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Recurrence
2
Neoplasms
2
Meningeal Carcinomatosis
2
Insulin Resistance
2
Infertility, Female
2
Hyperandrogenism
2
Diabetes, Gestational
2
Carcinoma, Non-Small-Cell Lung
2
Atypical Squamous Cells of the Cervix
2
Anemia
2
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Thrombocytopenia
1
Stroke
1
Stomatitis
1
Stomach Neoplasms
1
Squamous Intraepithelial Lesions
1
Rectal Neoplasms
1
Psoriasis
1
Prostatic Neoplasms
1
Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
pembrolizumab
37
Gemcitabine
29
Nivolumab
20
Cisplatin
19
atezolizumab
15
avelumab
14
Docetaxel
13
enfortumab vedotin
10
Carboplatin
10
durvalumab
9
Magnetic Resonance Spectroscopy
9
Ipilimumab
8
Paclitaxel
7
Pemetrexed
6
toripalimab
5
cabozantinib
5
Fluorodeoxyglucose F18
5
sacituzumab govitecan
4
cabazitaxel
4
Taxes
4
vinflunine
3
tremelimumab
3
pemigatinib
3
X-Rays
3
Standard of Care
3
Specimen Handling
3
Radiotherapy
3
Mitomycin
3
Immunotherapy
3
Immunoglobulin G
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Transitional Cell
×
Folic Acid
×
Clear all
NCT03193788
2017-06-21
PREMIER
Asan Medical Center
Phase 3
Unknown
74 enrolled